In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of $100.00. The company’s shares closed last ...
Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal ... much needed and clinically superior relief to patients suffering from chronic pain,” said Dan ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Zacks.com on MSN3d
Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain?Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement, unanimously ...
TRICARE is announcing the Department of Defense’s new electronic health record system will be replacing TRICARE and the old ...
Dr. Sue Mitchell is an experienced gastroenterologist with a background in functional medicine, internal medicine and ...
After hours: 7:51:05 p.m. EST ...
After hours: 7:07:16 pm GMT-5 ...
RA takes a toll on mental health, with some estimates that up to 22% of RA patients have depression. In one study, more than 50% of RA patients who reached remission sustained it for at least two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback